mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
Roscovitine |
GDSC1000 |
pan-cancer |
AAC |
0.04 |
0.6 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.6 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |